77 related articles for article (PubMed ID: 17173313)
1. Patent foramen ovale: standards for a preclinical model of prevalence, structure, and histopathologic comparability to human hearts.
Hara H; Virmani R; Ladich E; Mackey-Bojack S; Titus JL; Karnicki K; Stewart M; Pelzel JM; Schwartz RS
Catheter Cardiovasc Interv; 2007 Feb; 69(2):266-73. PubMed ID: 17173313
[TBL] [Abstract][Full Text] [Related]
2. Patent foramen ovale closure by radiofrequency thermal coaptation: first experience in the porcine model and healing mechanisms over time.
Hara H; Jones TK; Ladich ER; Virmani R; Auth DC; Eichinger JE; Sommer RJ; Van Tassel RA; Schwartz RS
Circulation; 2007 Aug; 116(6):648-53. PubMed ID: 17664371
[TBL] [Abstract][Full Text] [Related]
3. [Patent foramen ovale: an anatomical study. Apropos of 500 consecutive autopsies].
Penther P
Arch Mal Coeur Vaiss; 1994 Jan; 87(1):15-21. PubMed ID: 7811147
[TBL] [Abstract][Full Text] [Related]
4. [Thrombophilia and patent foramen ovale in young stroke patients].
Carod-Artal FJ; Vilela Nunes S; Portugal D
Neurologia; 2006 Dec; 21(10):710-6. PubMed ID: 17106824
[TBL] [Abstract][Full Text] [Related]
5. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
[TBL] [Abstract][Full Text] [Related]
6. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
[TBL] [Abstract][Full Text] [Related]
7. Anatomy of the patent foramen ovale for the interventionalist.
McKenzie JA; Edwards WD; Hagler DJ
Catheter Cardiovasc Interv; 2009 May; 73(6):821-6. PubMed ID: 19330826
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
[TBL] [Abstract][Full Text] [Related]
9. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
12. Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation.
Knecht S; Wright M; Lellouche N; Nault I; Matsuo S; O'Neill MD; Lomas O; Deplagne A; Bordachar P; Sacher F; Derval N; Hocini M; Jaïs P; Clémenty J; Haïssaguerre M
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1236-41. PubMed ID: 18662179
[TBL] [Abstract][Full Text] [Related]
13. Patent foramen ovale and migraine.
Post MC; Luermans JG; Plokker HW; Budts W
Catheter Cardiovasc Interv; 2007 Jan; 69(1):9-14. PubMed ID: 17143907
[TBL] [Abstract][Full Text] [Related]
14. Quantitative trait loci modifying cardiac atrial septal morphology and risk of patent foramen ovale in the mouse.
Kirk EP; Hyun C; Thomson PC; Lai D; Castro ML; Biben C; Buckley MF; Martin IC; Moran C; Harvey RP
Circ Res; 2006 Mar; 98(5):651-8. PubMed ID: 16484617
[TBL] [Abstract][Full Text] [Related]
15. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
Dubiel M; Bruch L; Liebner M; Schmehl I; Winkelmann A; Rux S; Sonntag S; Wulff H; Grad MO; Kleber FX
J Interv Cardiol; 2007 Aug; 20(4):275-81. PubMed ID: 17680857
[TBL] [Abstract][Full Text] [Related]
16. Comparison of contemporary devices used for transcatheter patent foramen ovale closure.
Spies C; Reissmann U; Timmermanns I; Schräder R
J Invasive Cardiol; 2008 Sep; 20(9):442-7. PubMed ID: 18762672
[TBL] [Abstract][Full Text] [Related]
17. Cryptogenic emboli in patients with patent foramen ovale or atrial septal defect associated with the use of nonsteroidal anti-inflammatory drugs.
Ferguson MA; Mackay SM; Ramchandani SR; Thurber JS; Curran MJ; DeGraba TJ
Cardiology; 2009; 113(1):20-4. PubMed ID: 18931493
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic complications after pneumonectomy: atrial inflow obstruction and reopening of the foramen ovale.
Aigner C; Lang G; Taghavi S; Reza-Hoda MA; Marta G; Baumgartner H; Klepetko W
Eur J Cardiothorac Surg; 2008 Feb; 33(2):268-71. PubMed ID: 18061472
[TBL] [Abstract][Full Text] [Related]
19. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
Spies C; Khandelwal A; Timmermanns I; Schräder R
Am J Cardiol; 2008 Oct; 102(7):902-6. PubMed ID: 18805119
[TBL] [Abstract][Full Text] [Related]
20. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine.
Domitrz I; Mieszkowski J; Kamińska A
Headache; 2007 Oct; 47(9):1311-8. PubMed ID: 17927647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
